Skip to main content
Torsten Vahl, MD, Cardiology, New York, NY, New York-Presbyterian Hospital

TorstenPeterVahlMD

Cardiology New York, NY

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Overview of Dr. Vahl

Dr. Torsten Vahl is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Philipps University of Marburg Faculty of Medicine and has been in practice 19 years. He is one of 689 doctors at New York-Presbyterian Hospital and one of 316 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 100 publications and over 500 citings.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2008 - 2012
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2008
  • Philipps University of Marburg Faculty of Medicine
    Philipps University of Marburg Faculty of MedicineClass of 1998

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - 2025
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Focus on Trends in Surgical and Transcatheter Aortic Valve Replacement Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Prior Cardiac Surgery in...  
    Vinod H Thourani, Lars Svensson, Kevin L Greason, Torsten P Vahl, Rakesh M Suri, Martin B Leon, Susheel K Kodali, Tamim Nazif, ScienceDirect

Lectures

  • Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion 
    CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
  • Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion 
    CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/15/2019
  • Case: JenaValve for Pure Aortic Regurgitation 
    CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
  • Join now to see all

Press Mentions

  • New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial Fibrillation
    New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial FibrillationAugust 3rd, 2021
  • TAVR Expected to See Rapid Growth in Next 5 Years
    TAVR Expected to See Rapid Growth in Next 5 YearsFebruary 24th, 2020
  • 6 Hot Topics in Interventional Cardiology at TCT 2019
    6 Hot Topics in Interventional Cardiology at TCT 2019November 4th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations